Myriad Genetics Inc (MYGN)
18.83
+0.23
(+1.24%)
USD |
NASDAQ |
Apr 24, 13:27
Myriad Genetics Revenue (TTM): 753.20M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 753.20M |
| September 30, 2023 | 734.40M |
| June 30, 2023 | 698.90M |
| March 31, 2023 | 694.70M |
| December 31, 2022 | 678.40M |
| September 30, 2022 | 661.40M |
| June 30, 2022 | 672.30M |
| March 31, 2022 | 682.40M |
| December 31, 2021 | 690.60M |
| September 30, 2021 | 675.00M |
| June 30, 2021 | 600.90M |
| March 31, 2021 | 575.50M |
| September 30, 2020 | 597.50M |
| June 30, 2020 | 638.60M |
| March 31, 2020 | 760.80M |
| December 31, 2019 | 813.40M |
| September 30, 2019 | 835.10M |
| June 30, 2019 | 851.10M |
| March 31, 2019 | 829.60M |
| December 31, 2018 | 796.10M |
| September 30, 2018 | 767.20M |
| June 30, 2018 | 743.70M |
| March 31, 2018 | 707.60M |
| December 31, 2017 | 721.40M |
| September 30, 2017 | 730.00M |
| Date | Value |
|---|---|
| June 30, 2017 | 728.70M |
| March 31, 2017 | 744.00M |
| December 31, 2016 | 737.60M |
| September 30, 2016 | 734.40M |
| June 30, 2016 | 740.40M |
| March 31, 2016 | 757.20M |
| December 31, 2015 | 746.70M |
| September 30, 2015 | 737.80M |
| June 30, 2015 | 723.10M |
| March 31, 2015 | 721.95M |
| December 31, 2014 | 724.87M |
| September 30, 2014 | 744.53M |
| June 30, 2014 | 778.20M |
| March 31, 2014 | 763.60M |
| December 31, 2013 | 737.15M |
| September 30, 2013 | 682.23M |
| June 30, 2013 | 613.20M |
| March 31, 2013 | 572.01M |
| December 31, 2012 | 545.32M |
| September 30, 2012 | 518.99M |
| June 30, 2012 | 496.00M |
| March 31, 2012 | 470.45M |
| December 31, 2011 | 443.05M |
| September 30, 2011 | 420.68M |
| June 30, 2011 | 402.08M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
575.50M
Minimum
Mar 2021
851.10M
Maximum
Jun 2019
700.79M
Average
686.50M
Median
Revenue (TTM) Benchmarks
| Stryker Corp | 20.50B |
| Haemonetics Corp | 1.270B |
| Perspective Therapeutics Inc | 0.00 |
| Electromed Inc | 51.69M |
| Xtant Medical Holdings Inc | 91.30M |